Prostate cancer

Showing 9 of 0 results

• Real-world patient characteristics, treatment patterns, and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC): insights by PTEN status

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Treatment patterns
  • Prostate cancer
• Assessment of racial/ethnic inequities in uptake of PSMA-PET scans among patients with metastatic prostate cancer in the United States

  ASCO Annual Meeting

  • Health equity
  • Prostate cancer
• Genitourinary cancer research is incredibly promising, and real-world evidence is a key part of it
  • Real-world evidence
  • Case study
  • Prostate cancer
  • Genitourinary cancer
• Genitourinary cancer insights: Leveraging RWE to learn from the experience of every patient
  • Real-world evidence
  • Video
  • Prostate cancer
  • Webinar
  • Genitourinary cancer
• Real-world treatment patterns in patients diagnosed with metastatic castration-resistant prostate cancer in the US, 2018-2023

  ASCO GU

  • Publication summary
  • Publications
  • Prostate cancer
• Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study

  Annals of Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Metastatic breast cancer
  • Colorectal cancer
  • Non-small cell lung cancer
  • Prostate cancer
• Plasma circulating tumor DNA (ctDNA) fraction and real-world overall survival (rwOS) in metastatic castration resistant prostate cancer (mCRPC)

  ASCO Annual Meeting

  • Publications
  • Drug discovery
  • Prostate cancer
• Association of BRCA alteration type with real-world outcomes to PARP inhibitors in patients with metastatic castrate-resistant prostate cancer

  ASCO Annual Meeting

  • Publications
  • Drug discovery
  • Prostate cancer
• Prognostic significance of cancer patient reported outcomes in cancer

  Journal of Oncology Practice

  • Publications
  • Drug discovery
  • Prostate cancer